Syndicated Content about Biotechnology, Pharmaceutical and Healthcare
Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers.
Showing News Articles 1–25 of 230,000+
Videoticker Frankfurter Börsenbrief - 22.05.2013...
Targeting High-Risk Neighborhoods May Eliminate Tuberculosis
Identifying specific neighborhoods that have a high incidence of tuberculosis followed by testing and treating the residents proved to eliminate those communities’ cases of tuberculosis, according to new research published in the American Journal of Public Health. A latent tuberculosis infection, called LTBI, accounts for the development of most
Vorwürfe der US-Gesundheitsbehörde machen Boehringer Ingelheim zu schaffen
Der deutsche Pharmakonzern Boehringer Ingelheim nimmt Vorwürfe der US-amerikanischen Arzneimittelbehörde FDA sehr ernst, gegen Produktionsstandards verstoßen zu haben. Die Behörde hatte am Diensta...
U.S. government taps GlaxoSmithKline for new antibiotics
LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism.
Pharma's joy of tax, Irish style
Earlier this week, Nigel Clerkin, CFO of Irish company Elan, boasted of the "minimal tax leakage" from its double-digit royalty revenue from Biogen Idec for the blockbuster multiple sclerosis drug Tysabri (natalizumab): it has an.....
Corgenix Medical Collaborates With Eli Lilly To Develop Diagnostic Technology
INDIANAPOLIS (dpa-AFX) - Corgenix Medical Corp. (CONX.OB) announced that it has entered into a collaboration agreement with Eli Lilly and Co.(LLY) to develop diagnostic technology in support of a ...
Evotec-Aktie: Jetzt einsteigen!
Hamburg - Letzte Woche hat das Wirkstoffforschungs- und -entwicklungsunternehmen Evotec (ISIN DE0005664809/ WKN 566480) die Finanzergebnisse und die Geschäftsentwicklung für das erste Quartal 2013 ...
Soligenix Announces Issuance of US Patent for its ThermoVax' Technology
PRINCETON, N.J., May 22, 2013 /PRNewswire/ --Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammato...
Lifestyle Change and the Prevention of Cognitive Decline
Can a change from a sedentary lifestyle to one of moderate physical activity have a beneficial effect on cognitive function in the elderly? Current Opinion in Psychiatry
Vaginal Microbicides to Reduce the Risk of HIV Acquisition
How effective are vaginal microbicides in preventing sexual acquisition of HIV in women? BMC Infectious Diseases
Los Angeles voters OK move to curtail medical marijuana outlets
LOS ANGELES (Reuters) - Voters strongly supported a ballot measure to sharply curtail the number of medical marijuana dispensaries permitted to operate in Los Angeles while boosting taxes on the sale of pot for health reasons, election returns early...
Celesio AG: Neues 13-Wochenhoch (16.55 Euro, Long)
Unsere Produkte: Wave-XXL-Call DX6N5HWave-XXL-Put DX3BGHCelesio AG (WKN: CLS100)Signal vom 22.05.2013 12:49:56 bei 16.55 EuroNeues 13-WochenhochFür spekulativ orientierte Anleger, die von einer tre...
Celesio AG: Neues 26-Wochenhoch (16.55 Euro, Long)
Unsere Produkte: Wave-XXL-Call DX6N5HWave-XXL-Put DX3BGHCelesio AG (WKN: CLS100)Signal vom 22.05.2013 12:49:56 bei 16.55 EuroNeues 26-WochenhochFür spekulativ orientierte Anleger, die von einer tre...
Celesio AG: Neues 52-Wochenhoch (16.55 Euro, Long)
Unsere Produkte: Wave-XXL-Call DX6N5HWave-XXL-Put DX3BGHCelesio AG (WKN: CLS100)Signal vom 22.05.2013 12:49:56 bei 16.55 EuroNeues 52-WochenhochFür spekulativ orientierte Anleger, die von einer tre...
Citigroup stuft Bristol-Myers von Neutral auf Buy hoch
Citigroup stuft Bristol-Myers von Neutral auf Buy hoch (© BörseGo AG 2013 - Autor: Thomas Gansneder, Redakteur)...
GSK Says Lowering Prices in China Caused Higher Sales
Want to increase revenues in China? You might try lowering prices. It seems to have worked for GlaxoSmithKline. In 2009, the company reduced the cost of its allergy treatment, Avamys nasal spray. The number of units sold jumped to five times th...
CALGARY, May 22, 2013 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced preliminary results from its U.S. Phase 2 clinical trial in patients with metasta...
Mittags Mashup (ATX -1,37%): Sanochemia, Verbund, voestalpine, Andritz, Amazon, ÖVAG, Immofinanz
Hinweis: Das hier Gezeigte ist eine Momentaufnahme, aktuell ist das jederzeit unter http://www.finanzmarktmashup.at aktuell aufrufbar. Was die wichtigsten Finanzmarktmedien Österreichs halt gerade ...
EU mergers and takeovers (May 22)
BRUSSELS, May 22 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Immune system cancer drugs tipped to be a $35 billion market
LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year.
16.4
May 22 (Reuters) - ...
GSK to cut 120 jobs at Australian facility
GSK to cut 120 jobs at Australian facility
US Organic Group develops over-the-counter organic anti-itch ointment
US Organic Group has developed an over-the-counter organic anti-itch ointment, Anti Itchbalm, for itchy skin.
Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
French drug major Sanofi (Euronext: SAN) and US biotech partner Regeneron Pharmaceuticals (Nasdaq: REGN) announced that the New England Journal of Medicine published on-line the positive Phase IIa study results of dupilumab (SAR231893REGN668) in pati...
CORRECTED-RESEARCH ALERT-Insmed: Canaccord Genuity raises price target
(Corrects to show that the target price is in U.S. dollar not C$)
